First Trust NYSE Arca Biotechnology Index Fund (NYSEARCA:FBT) Reaches New 52-Week High – What’s Next?

First Trust NYSE Arca Biotechnology Index Fund (NYSEARCA:FBT) reached a new 52-week high on Wednesday . The company traded as high as $229.01 and last traded at $229.0890, with a volume of 3758 shares. The stock had previously closed at $226.09.

First Trust NYSE Arca Biotechnology Index Fund Trading Down 0.5%

The business has a 50-day moving average price of $209.61 and a 200-day moving average price of $208.84. The stock has a market cap of $2.54 billion, a PE ratio of 21.72 and a beta of 0.68.

Institutional Trading of First Trust NYSE Arca Biotechnology Index Fund

Institutional investors and hedge funds have recently modified their holdings of the stock. First Trust Advisors LP raised its position in shares of First Trust NYSE Arca Biotechnology Index Fund by 49,660.7% during the 1st quarter. First Trust Advisors LP now owns 3,515,093 shares of the company’s stock worth $705,900,000 after purchasing an additional 3,508,029 shares during the last quarter. Northwestern Mutual Wealth Management Co. boosted its stake in shares of First Trust NYSE Arca Biotechnology Index Fund by 4,370.5% in the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 577,231 shares of the company’s stock worth $119,210,000 after acquiring an additional 564,319 shares during the last quarter. 360 Financial Inc. purchased a new stake in shares of First Trust NYSE Arca Biotechnology Index Fund during the fourth quarter worth approximately $14,887,000. Stonebridge Financial Group LLC acquired a new position in First Trust NYSE Arca Biotechnology Index Fund in the 4th quarter valued at $14,734,000. Finally, Morgan Stanley lifted its holdings in First Trust NYSE Arca Biotechnology Index Fund by 18.2% in the 4th quarter. Morgan Stanley now owns 401,201 shares of the company’s stock valued at $82,856,000 after purchasing an additional 61,755 shares in the last quarter.

First Trust NYSE Arca Biotechnology Index Fund Company Profile

The First Trust NYSE Arca Biotechnology Index Fund (FBT) is an exchange-traded fund that is based on the NYSE Arca Biotechnology index. The fund tracks an equal-weighted index of US biotechnology stocks. FBT was launched on Jun 19, 2006 and is managed by First Trust.